Navigation Links
Proposed drug may reverse Huntington's disease symptoms
Date:6/20/2012

With a single drug treatment, researchers at the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine can silence the mutated gene responsible for Huntington's disease, slowing and partially reversing progression of the fatal neurodegenerative disorder in animal models.

The findings are published in the June 21, 2012 online issue of the journal Neuron.

Researchers suggest the drug therapy, tested in mouse and non-human primate models, could produce sustained motor and neurological benefits in human adults with moderate and severe forms of the disorder. Currently, there is no effective treatment.

Huntington's disease afflicts approximately 30,000 Americans, whose symptoms include uncontrolled movements and progressive cognitive and psychiatric problems. The disease is caused by the mutation of a single gene, which results in the production and accumulation of toxic proteins throughout the brain.

Don W. Cleveland, PhD, professor and chair of the UC San Diego Department of Cellular and Molecular Medicine and head of the Laboratory of Cell Biology at the Ludwig Institute for Cancer Research, and colleagues infused mouse and primate models of Huntington's disease with one-time injections of an identified DNA drug based on antisense oligonucleotides (ASOs). These ASOs selectively bind to and destroy the mutant gene's molecular instructions for making the toxic huntingtin protein.

The singular treatment produced rapid results. Treated animals began moving better within one month and achieved normal motor function within two. More remarkably, the benefits persisted, lasting nine months, well after the drug had disappeared and production of the toxic proteins had resumed.

"For diseases like Huntington's, where a mutant protein product is tolerated for decades prior to disease onset, these findings open up the provocative possibility that transient treatment
'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Proposed testosterone testing of some female olympians challenged by Stanford scientists
2. Treatment of childhood OSA reverses brain abnormalities
3. Combination of 2 drugs reverses liver tumors
4. In Mice, Drug Reverses Symptoms of Condition Linked to Autism
5. Kidney Disease May Be as Harmful to Heart as Heart Attack: Study
6. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
7. Gum Disease, HPV May Play Role in Head & Neck Cancers
8. Device implanted in brain has therapeutic potential for Huntingtons disease
9. Control gene for conveyor belt cells could help improve oral vaccines, treat intestinal disease
10. Fruit flies reveal mechanism behind ALS-like disease
11. 1960s-era anti-cancer drug points to treatments for Lou Gehrigs disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Proposed drug may reverse Huntington's disease symptoms
(Date:8/4/2015)... ... August 05, 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed ... update, MillionaireMatch.com has been ranked as the best dating service in the segment. , ... life companion. It is essential that people find the right dating platform so that ...
(Date:8/4/2015)... ... ... How cool is it to check in at your favorite place and be ... soon allow you to do just that. , Ahhaa is releasing the next version ... , Users will soon get to share what inspires them about their favorite places ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sponsored by Gila River Casinos, the charity ... 501(c) nonprofit organization. , According to the New Foundation AZ spokesperson , the ... package that includes a complimentary foursome for the tournament, as well as getting their ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... technology platform that uses Cloud innovation to consolidate oncology patient assistance programs. Through ... a single point of access. assistPoint is an enterprise level, cloud-based application and ...
(Date:8/4/2015)... ... ... Rhode Island Medical Imaging (RIMI) is pleased to announce the opening of ... Road in Lincoln, RI. This satellite office will provide x-ray and ultrasound exams. ... hours in the state, which includes evenings and weekends. , “This satellite office ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:assistPoint.com Web Site Launched 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2
... council to provide full openness and transparency WASHINGTON, ... Partnership to Improve Patient Care (PIPC) released today ... Health and Human Services, announcement of members of ... "PIPC applauds HHS for moving rapidly ...
... and only guaranteed ultrasound repair solution makes efficient use ... Pa., March 19 MEDRAD, INC., Multi Vendor Service ... only guaranteed repair solution on select ultrasound probes. Enabled ... to spend less on costly exchanges and replacements by ...
... Media may now register to attend TCT 2009 ... the Cardiovascular Research Foundation. TCT gathers leading medical ... present and discuss the latest developments in the ... in its 21st year, TCT brings state-of-the-art techniques ...
... Brain hemorrhage might explain the actress, sudden death, doctors ... results of an autopsy on Natasha Richardson expected later ... suffered devastating brain damage after a seemingly minor fall ... New York City medical examiner was performing the autopsy. ...
... Vaccine coverage rates reach 95% - rival many ... the Seattle-based international organization that increases developing nations, ... vaccination rates for its heath system strengthening program ... study show high rates of immunization that rival ...
... Health Protection Act Will End Pre-Existing Coverage Limitations ... Care for Children With Chronic IllnessWASHINGTON, March 19 ... a national, non-profit organization dedicated to the mission ... health care through public policy reform at the ...
Cached Medicine News:Health News:PIPC Statement on Federal CER Coordinating Council 2Health News:MEDRAD Multi Vendor Service Launches TotalRepair(SM) on Select Ultrasound Probes 2Health News:MEDRAD Multi Vendor Service Launches TotalRepair(SM) on Select Ultrasound Probes 3Health News:Media registration now open for TCT 2009 2Health News:NYC Medical Examiner Performing Autopsy on Natasha Richardson 2Health News:NYC Medical Examiner Performing Autopsy on Natasha Richardson 3Health News:VillageReach Announces Results of Five-Year Health System Improvement Program in Mozambique 2Health News:National Patient Advocate Foundation Applauds Senators Lautenberg and Brown and Representatives Schwartz and DeGette for Introduction of Legislation to Protect Health Care Coverage for Children 2
(Date:8/4/2015)... SOUTHAMPTON , England ... Ltd (ASX: PXS) and UK biotechnology company Synairgen plc (LSE: ... to develop a selective inhibitor to the lysyl oxidase type ... pulmonary fibrosis (IPF). IPF affects in the ... expected to produce global revenues in excess of $1.1 billion ...
(Date:8/4/2015)... -- On August 3, 2015, a press conference on anti-virus ... donation ceremony of a million masks by Wuhan Longfeixiang Technology ... . Wuhan Longfeixiang Technology ... Hubei Longfeixiang Industrial Group, which has successfully developed the ... anti-pollution mask, filling the global gap for masks of ...
(Date:8/4/2015)... ALGONQUIN, Ill. , Aug. 4, 2015 /PRNewswire/ ... of dental supplies and equipment, today announced the ... of Medical Products Laboratories, Inc. ("MPL PDCMD"). MPL ... materials used in preventive and restorative dental procedures. ... strategic expansion of our business in attractive, high-growth ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
... Calif., Sept. 21 VIVUS, Inc. (Nasdaq: ... two-year study of QNEXA® (phentermine/topiramate) Controlled Release Capsules, an ... affects approximately one-third of adult Americans. ... 52-week extension study for a subset of patients who ...
... the GRACE ( G ender, R ace A ... published in the September 21st issue of the Annals ... treatment-experienced adult women with HIV-1 to examine gender differences in ... a division of Centocor Ortho Biotech Services, LLC, the GRACE ...
Cached Medicine Technology:New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 2New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 3New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 4New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 5New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 6Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 2Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 3Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 4Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 5Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 6Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 7Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 8
... Human Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) ... liver, which specifically binds and modulates the ... role of IGFBP-1 has not been completely ... suggests that IGFBP-1 may be involved in ...
... in the adrenal gland and gonads, is ... estrone, both of which may be subsequently ... androgenic activity, estimated at ~(less than or ... serum androstenedione levels often exceed testosterone in ...
... II (IGF-II) is a 7.5 kDa peptide which ... postulated to have mitogenic and metabolic actions involved ... mediated by binding to target cell receptors. IGF-II ... IGF receptor, a monomeric protein which also serves ...
... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
Medicine Products: